Why the study?
Catheter ablation for atrial fibrillation is highly efficacious for rhythm control to reduce cognitive decline, but left atrial ablation has been shown to cause MRI-detected silent cerebral lesions.
What is the risk of MRI-detected silent cerebral lesions following catheter ablation for atrial fibrillation, and how can newer ablation technologies mitigate this risk?
What is the risk of MRI-detected silent cerebral lesions following catheter ablation for atrial fibrillation, and how can newer ablation technologies mitigate this risk?
This review highlights the risk of silent cerebral lesions following AF ablation and discusses strategies and newer technologies to mitigate this risk.
Atrial fibrillation is associated with neurocognitive comorbidities such as stroke and dementia. Evidence suggests that rhythm control-especially if implemented early-may reduce the risk of cognitive decline. Catheter ablation is highly efficacious for restoring sinus rhythm in the setting of atrial fibrillation; however, ablation within the left atrium has been shown to result in MRI-detected silent cerebral lesions. In this state-of-the-art review article, we discuss the balance of risk between left atrial ablation and rhythm control. We highlight suggestions to lower the risk, as well as the evidence behind newer forms of ablation such as very high power short duration radiofrequency ablation and pulsed field ablation.
No takes yet. Share an insight, caveat, or question.
Calvert et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: